Boosting health pioneers. We invest in early stage start-ups in different sectors: medtech, life science, biotech, mental health, public health, well-being.
Location: Switzerland
Mentions in press and media 17
| Date | Title | Description |
| 29.11.2024 | A New Dawn for Health Innovation: Lichtsteiner Foundation Joins Forces with Venture Kick | In the heart of Switzerland, a revolution is brewing. The Lichtsteiner Foundation has stepped into the spotlight, joining forces with Venture Kick to ignite health innovation. This partnership is not just a merger of resources; it’s a bold ... |
| 28.11.2024 | Lichtsteiner Foundation joins Venture Kick | The Lichtsteiner Foundation's mission is to advance healthcare by empowering pioneers to bring their groundbreaking inventions to life. The foundation invests in early-stage Swiss startups across life sciences, medical technology, mental h... |
| 28.11.2024 | Lichtsteiner Foundation partners with Venture Kick to drive health innovation | The Lichtsteiner Foundation's mission is to advance healthcare by empowering pioneers to bring their groundbreaking inventions to life. The foundation invests in early-stage Swiss startups across life sciences, medical technology, mental he... |
| 23.05.2024 | Revolutionizing Cell and Gene Therapy Manufacturing: Limula's $6.8M Seed Round | Limula, a pioneering biotech company established in 2020, has recently secured a substantial $6.8M seed round to transform the landscape of cell and gene therapy manufacturing. This significant funding injection is poised to propel Limula t... |
| 21.05.2024 | Limula secures USD 6.8 million to revolutionize Cell and Gene Therapy manufacturing | Limula secures USD 6.8 million to revolutionize Cell and Gene Therapy manufacturing 21.05.2024 13:00, Rita Longobardi linkedIn facebook twitter instagram youtube --> The company's innovative technology integrates a bioreactor and centrif... |
| 21.05.2024 | Limula raises $6.8M to scale cell and gene therapies | Over the past decade, several groundbreaking cell and gene therapy products have been approved in the US and Europe that transform stem and immune cells into "living cures", giving hope to millions of people with life-threatening... |
| 03.05.2024 | USD 6 million to fight a silent epidemic | According to the World Health Organization (WHO), there are an estimated 374 million new infections every year, including four curable sexually transmitted infections (STIs), namely chlamydia, gonorrhea, syphilis and trichomoniasis. Very o... |
| 31.08.2022 | Healios AG secures substantial funds to meet demand | |
| 25.07.2022 | Impact investment to boost health innovations | |
| 31.05.2021 | Muvon Therapeutics picks up speed in addressing urinary incontinence |
Show more